This website uses cookies
Read our Privacy policy and Terms of use for more information.
Find the content you are looking for on Diabetech by searching the desired device, company, or topic.
Feb 23, 2026
•
1 min read
Encapsulated neonatal pig islet cells, implanted without immunosuppression in the OPF-310 trial, cut a type 1 diabetes patient’s insulin needs in half at six months, with further maturation expected.
Feb 19, 2026
2 min read
After an initial beta launch, integration of the Eversense 365 continuous glucose monitor has officially launched on the twiist insulin pump.
Feb 18, 2026
We go beyond our Youtube review and cover insurance hurdles, algorithm performance, infusion set challenges, funny stories, and answer follower questions.
The device has a customizable 7-inch display designed to display up to six CGM readings at one time making it great for people with diabetes.
Medtronic advances its next-gen tubed pump toward FDA clearance while testing begins on an enhanced algorithm called Vivera.
Feb 17, 2026
The first patients have received its investigational Portal Insulin as development moves toward larger trials in 2027.